NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study-Reference-Cited by-同舟云学术

NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study

Published:2018-06-19 Issue:9 Volume:53 Page:1065-1078
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Kakuta Yoichi^ORCID, ,Kawai Yosuke,Okamoto Daisuke,Takagawa Tetsuya,Ikeya Kentaro,Sakuraba Hirotake,Nishida Atsushi,Nakagawa Shoko,Miura Miki,Toyonaga Takahiko,Onodera Kei,Shinozaki Masaru,Ishiguro Yoh,Mizuno Shinta,Takahara Masahiro,Yanai Shunichi,Hokari Ryota,Nakagawa Tomoo,Araki Hiroshi,Motoya Satoshi,Naito Takeo,Moroi Rintaro,Shiga Hisashi,Endo Katsuya,Kobayashi Taku,Naganuma Makoto,Hiraoka Sakiko,Matsumoto Takayuki,Nakamura Shiro,Nakase Hiroshi,Hisamatsu Tadakazu,Sasaki Makoto,Hanai Hiroyuki,Andoh Akira,Nagasaki Masao,Kinouchi Yoshitaka,Shimosegawa Tooru,Masamune Atsushi,Suzuki Yasuo

Funder

Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/article/10.1007/s00535-018-1486-7/fulltext.html

Reference31 articles.

1. Matsuoka K, Kobayashi T, Ueno F, Matsui T, Hirai F, Inoue N, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease. J Gastroenterol. 2018;53(3):305–53.

2. Hibi T, Naganuma M, Kitahora T, Kinjyo F, Shimoyama T. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis. J Gastroenterol. 2003;38(8):740–6.

3. Khan KJ, Dubinsky MC, Ford AC, Ullman TA, Talley NJ, Moayyedi P. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol. 2011;106(4):630–42.